PTHS vs QGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PTHS

47.1
AI Score
VS
PTHS Wins

QGEN

44.1
AI Score

Investment Advisor Scores

PTHS

47score
Recommendation
HOLD

QGEN

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PTHS QGEN Winner
Forward P/E 0 15.5763 Tie
PEG Ratio 0 1.3433 Tie
Revenue Growth 0.0% 2.9% QGEN
Earnings Growth 0.0% -19.2% PTHS
Tradestie Score 47.1/100 44.1/100 PTHS
Profit Margin -199.5% 18.2% QGEN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PTHS 1M: -53.4% · 3M: -67.4% QGEN 1M: +10.7% · 3M: +16.4%

Current Technical Phase

PTHS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -21.1%), weak momentum, RSI 29

RSI (14): 29.3 · Price: $9.45

QGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.0% over 20 days), RSI 66

RSI (14): 66.1 · Price: $50.31

Fundamentals Snapshot

Metric PTHS QGEN
Market Cap — —
Forward P/E -1.7 19.0
Trailing P/E — 27.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.8% 0.7%
Operating Margin -1.0% 0.3%
EPS -27.53 1.85
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, PTHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.